Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheum and Race: Where Are We?

David A. Fox, MD  |  Issue: May 2008  |  May 1, 2008

Now, it’s unlikely that this is due to a practice of deliberate exclusion, but it seems to me that this is a topic that gets far too little attention from the ACR. If disparities in the composition of our profession have anything to do with disparities in the outcomes of our patients, then neglect of this issue is not a tenable option. We have an opportunity to take a stand this year on the need for adequate racial diversity in rheumatology, and, more importantly, to take action as the ACR constructs its plan to deal with the well-documented and growing shortage of rheumatologists in the United States.

These are challenging times for the practice of rheumatology and for our academic rheumatology units, but let’s not shortchange our accomplishments, our strengths, and—most important—our values. Our character, as individuals and as a profession, is defined much more clearly in times of stress than in times of comfort. How we address disparities in the outcomes of rheumatic diseases will be an important element of that definition.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Epilogue: The rheumatologist from New York mentioned earlier in this column now works for a different institution.

Dr. Fox is president of the ACR. Contact him via e-mail at [email protected].

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Fry RB, Ray MN, Cobaugh DJ, et al. Racial/ethnic disparities in patient-reported nonsteroidal antiinflammatory drug (NSAID) risk awareness, patient-doctor NSAID risk communication, and NSAID risk behavior. Arthritis Rheum. 2007;57(8):1539-1545.
  2. Suarez-Almazor M, Berrios-Rivera J, Cox V, et al. Initiation of disease-modifying antirheumatic drug therapy in minority and disadvantaged patients with rheumatoid arthritis. J Rheumatol. 2007; 34:2400-2407.
  3. Barrett K. Drug trials suffer from little diversity. ABC News. April 3, 2008. http://abcnews.go.com/Health/story? id=4569099. Last accessed April 8, 2008.
  4. Lubbes S. Thousands of U.S. deaths attributed to lack of health Insurance. Congressional Quarterly. January 11, 2008.
  5. Rom M, Fins JJ, Mackenzie CR. Articulating a justice ethic for rheumatology: A critical analysis of disparities in rheumatic diseases. Arthritis Rheum. 2007;57(8):1343-1345.

Page: 1 2 3 | Single Page
Share: 

Filed under:EthicsPresident's PerspectiveProfessional TopicsResearch Rheum Tagged with:AC&RArthritis Care & Researchdiscriminationnonsteroidal antiinflammatory drug (NSAID)Professionalismrace

Related Articles

    Racial Disparities in Rheumatology: What Are We Doing About It?

    September 20, 2018

    The data tell the story. Despite improvements in overall outcomes for common rheumatologic conditions, such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), white patients fare better than minority patients, and sometimes substantially better. Even with new biologic therapies that have significantly altered the course of disease for patients with RA, outcomes for minorities…

    G-Stock Studio / shutterstock.com

    Conquering Systemic Racism in Medicine

    October 19, 2020

    2020 has not only borne witness to a global pandemic, but also to increasing fervor in the fight for racial equity. In a wave of opposition to the systemic racism in the U.S., people have been in the streets demonstrating and protesting against social injustice and have taken to social media to promote political action….

    Speak Out Rheum: Racism’s Impact on Patient-Provider Relationships

    November 6, 2022

    “I tell everyone who comes into her room now, ‘You will not disrespect my daughter again. No one will,’” recounts Sarah’s mother. “Every time a [provider] acts rude to her, Sarah tells me, ‘Ma, I’m used to it now,’ and I have to insist ‘No! Baby, you should never get used to that.’ … Dr….

    Racial Bias Found in Pain Assessment, Management, Treatment Recommendations by Clinicians

    October 10, 2016

    In the world of evidence-based medicine, basing diagnosis and treatment decisions on belief instead of data seems anachronistic. And yet … clinicians are human, and humans live in culture, and culture is formed by beliefs, and beliefs (consciously or unconsciously) drive perception and, often, action. So a new study shining a light on racial bias…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences